| Ytd | -53.69% | |
| 1y | -82.97% |
| Open | 0.94 | Prev Close | 0.95 | Low | 0.90 | High | 0.97 | Mkt Cap | 3.31M |
| Vol | 73.17K | Avg Vol | 404.95K | EPS | -5.34 | P/E | N/A | Forward P/E | -0.65 |
| Beta | N/A | Short Ratio | 0.34 | Inst. Own | 1.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.01 | 200-d Avg | 1.78 | 1yr Est | 3.40 |
SXTP News
The partnership leverages USM’s established vector biology research expertise and investigator insig
WASHINGTON, Oct. 28, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW)
Gainers Axogen (NASDAQ:AXGN) stock rose 17.7% to $44.1 during Wednesday's pre-market session. T
All five completed patients (100%) reported much or very much improved clinical outcomes and tested
All five completed patients (100%) reported much or very much improved clinical outcomes and tested
Eyepoint Pharmaceuticals (NASDAQ: EYPT - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SX
After a scheduled interim analysis of the severe babesiosis study on October 1, 2026, the DSMB recom
After a scheduled interim analysis of the severe babesiosis study on October 1, 2026, the DSMB recom
60 Degrees Pharmaceuticals shares rose 12.50% in premarket trading Tuesday ahead of interim data fro
Gainers Flyte Aviation, Inc. Common Stock (AMEX:VJET) stock moved upwards by 34.0% to $2.17 during
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees" or the "Company"
Interim analysis results from clinical study evaluating tafenoquine in severe babesiosis ( NCT062073
Innoviva (NASDAQ: INVA - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SXTP - Get Free Re
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001946563/000121390026099702/ea0305442-8k_60degree.
Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's aft
60 Degrees Pharma (Nasdaq: SXTP) will present on demand at H.C. Wainwright beginning Sept. 11 and ho
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market
Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's aft
60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(0.90) per share which missed the analyst con
WASHINGTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW)
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday'
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW))) ("60 Degrees" or the "Company
WASHINGTON, July 30, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP, SXTPW)
Company plans to request an FDA meeting following the interim readout to discuss the regulatory path
https://x.com/PatentGrants/status/2081831140466569485 https://patentcenter.uspto.gov/applications/18
License expands collaboration with Florida State University to evaluate castanospermine for Powassan
60 Degrees Pharma (Nasdaq: SXTP) secures exclusive option to develop castanospermine for tick-borne
WASHINGTON, July 01, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW
License allows the Company to commence large-scale extraction of castanospermine from the seeds of
Enrollment is tracking ahead of schedule, allowing potential acceleration of key trial milestones Mi
WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP ; SXTP
60 Degrees Pharmaceuticals Inc. (NASDAQ: SXTP - Get Free Report) was the target of a significant dec
60 Degrees Pharmaceuticals Inc. (SXTP) might move higher on growing optimism about its earnings pros
FY 2025 net product revenues increased 65% to $1,005,000 Current shelf capacity exhausted after rais
60 Degrees files NDIN with FDA for Australian Chestnut Extract; May 25 decision deadline. FSU capsul
GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine)Collaboration designed t
